8 results
10-K
2023 FY
EX-10.12
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
herein to the contrary, any dispute, controversy or claim relating to the scope, validity, enforceability or infringement of any Patent shall
20-F
2018 FY
EX-2.3
AUTL
Autolus Therapeutics plc
23 Nov 18
Annual report (foreign)
12:00am
controversy that might arise with respect to the interpretation or implementation of this Section 2.
(b) It shall be a condition precedent
F-1/A
EX-10.2
AUTL
Autolus Therapeutics plc
8 Jun 18
Registration statement (foreign) (amended)
6:25am
applies.
19.2Dispute Resolution Procedures. Should any dispute, claim or controversy arise between the Parties relating to the validity, interpretation
F-1/A
EX-10.1
AUTL
Autolus Therapeutics plc
10 May 18
Registration statement (foreign) (amended)
5:19pm
referred to in this Agreement, including but not limited to a controversy or claim involving the validity, enforceability, interpretation … that the courts of England shall have exclusive jurisdiction to resolve any controversy or claim of whatsoever nature arising out of or relating in any manner
F-1/A
EX-10.2
zwkw1d307rzmurchj6
10 May 18
Registration statement (foreign) (amended)
5:19pm
F-1
EX-10.1
xfgyugwlesk0v4v
7 May 18
Registration statement (foreign)
4:45pm
F-1
EX-10.2
e3ggmf4
7 May 18
Registration statement (foreign)
4:45pm
- Prev
- 1
- Next